Back to today’s briefing

Story perspectives

Pfizer Faces Backlash for Concealing Heart Risk Data

7/19/2025

24 2

Summary

Story summary

Pfizer has come under fire for hiding crucial data that revealed heart damage and clotting risks associated with its products. Rather than confronting these alarming issues, the company chose to collaborate with Bristol Myers Squibb to promote Eliquis, a blood thinner, prioritizing profits over patient safety and leaving many to suffer while executives reveled in their financial success.

1 of 1

Story summary

Pfizer has come under fire for hiding crucial data that revealed heart damage and clotting risks associated with its products. Rather than confronting these alarming issues, the company chose to collaborate with Bristol Myers Squibb to promote Eliquis, a blood thinner, prioritizing profits over patient safety and leaving many to suffer while executives reveled in their financial success.